Hyperfine makes and sells the Swoop Portable MR Imaging System, a portable, ultra-low-field MRI device designed for point-of-care brain imaging. The Swoop system operates at 0.064 Tesla — far below conventional MRI field strengths of 1.5T to 3T — which makes it compact, portable, and usable outside a radiology suite. It plugs into a standard wall outlet and is operated via a tablet interface. The core value proposition is bringing brain imaging to the patient's bedside in an ICU, emergency department, or neurology office, rather than transporting critically ill patients to a conventional MRI scanner. The system runs on Hyperfine's proprietary Optive AI software, which uses deep learning to improve image quality and compensate for patient motion. Hyperfine sells the Swoop system primarily through direct capital sales at an MSRP of approximately $550,000 for its next-generation scanner, followed by annual service and software agreements sold in 36- or 60-month terms. Revenue is driven by unit volume and average selling price. Hyperfine targets three channels: U.S. hospitals (its original and largest channel), U.S. office-based neurology practices (a newer channel launched in mid-2025 following CMS reimbursement eligibility), and international healthcare providers served through third-party distributors. Hyperfine's growth strategy centers on expanding beyond hospital ICUs into emergency departments and neurology offices, pursuing multi-unit enterprise deals with hospital networks, and scaling internationally, including India following regulatory approval in late 2025.